Helios Investment Partners agreed to acquire a majority stake in a group of Morocco-based  medtech companies comprising Techniques Science Santé (T2S), IM Alliance, Cyclopharma and Binarios. The transaction provided an exit for CDG Invest which held a minority stake in T2S. Read more